Chunze Li

11PUBLICATIONS

60CO-AUTHORS

GlycoconjugatesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 09, 2026

Payload-Based Clinical Pharmacology Review of Approved Antibody-Drug Conjugates: Commonalities and Considerations for Streamlined Development.

|Apr 01, 2026

Follow-Up Bias in Tumor Dynamic Modeling: A Comparison of Classical and Neural-ODE Approaches.

David C Turner, Mark Laurie, Shuhui Li

|Jun 05, 2025

Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs.

Wei Gao, Jiang Liu, Cynthia J Musante

|Apr 25, 2025

Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma.

Junyi Li, Michael Z Liao, Justin Wilkins

|Apr 18, 2025

Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes.

Jiawen Zhu, Amy Schroeder, Sabine Frank

|May 29, 2024

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma.

Brendan Bender, Chi-Chung Li, Mathilde Marchand

Pageof 2

Frequent Collaborators

Bei Wang

Rong Deng

David C Turner

Jin Y Jin

Chi-Chung Li

Stefanie Hennig

Monika Kaewphluk

Matts Kågedal

Sandhya Girish

Whitney P Kirschbrown

Frequent Collaborators

Bei Wang

Rong Deng

David C Turner

Jin Y Jin